Chr. Hansen develops natural ingredient solutions for various industries. The company operates through Food Cultures & Enzymes and Health & Nutrition segments. Food Cultures & Enzymes produces cultures, enzymes, and probiotics for the dairy industry. The segment affects product taste, flavor, texture, shelf life, nutrition, and health benefits. The Health & Nutrition segment serves dietary supplement, pharmaceutical, infant formula, animal feed, and plant protection industries. Chr. Hansen was founded in 1843 and is headquartered in Denmark. As of January 29, 2024, the company operates as a subsidiary of Novozymes A/S.
| Indicator | Value |
|---|---|
| PER | 51.7 |
| EV/EBITDA | 29.7 |
| Price/Free Cash Flow' | 69.6 |
| ROIC | 27.0% |
| Net Debt/EBITDA | 2.1 |